Jazz Pharmaceuticals
JAZZ
#1899
Rank
ยฃ7.73 B
Marketcap
ยฃ127.29
Share price
1.67%
Change (1 day)
32.48%
Change (1 year)

Revenue for Jazz Pharmaceuticals (JAZZ)

Revenue in 2025 (TTM): ยฃ3.16 Billion

According to Jazz Pharmaceuticals's latest financial reports the company's current revenue (TTM ) is ยฃ3.11 Billion. In 2024 the company made a revenue of ยฃ3.24 Billion an increase over the revenue in the year 2023 that were of ยฃ3.00 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Jazz Pharmaceuticals from 2005 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) ยฃ3.16 B-2.5%
2024 ยฃ3.24 B7.74%
2023 ยฃ3.00 B-0.5%
2022 ยฃ3.02 B31.95%
2021 ยฃ2.29 B32.2%
2020 ยฃ1.73 B5.18%
2019 ยฃ1.64 B10.67%
2018 ยฃ1.48 B24.38%
2017 ยฃ1.19 B-0.68%
2016 ยฃ1.20 B34.89%
2015 ยฃ0.89 B18.67%
2014 ยฃ0.75 B42.44%
2013 ยฃ0.52 B45.88%
2012 ยฃ0.36 B106.96%
2011 ยฃ0.17 B55.61%
2010 ยฃ0.11 B41.82%
2009 ยฃ79.37 M72.31%
2008 ยฃ46.06 M40.14%
2007 ยฃ32.87 M43.54%
2006 ยฃ22.9 M84.16%
2005 ยฃ12.43 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Endo International
ENDPQ
ยฃ1.50 B-51.62%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
AmerisourceBergen
ABC
ยฃ190.83 B 6,019.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
ยฃ42.28 B 1,255.80%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Teva Pharmaceutical Industries
TEVA
ยฃ12.58 B 303.48%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel